Dr. Armine Baltayan has contributed to 3 publications.
LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ.
Baltayan, A., Naritoku, W. Y., Chaiwun, B., Tsao-Wei, D. D., Groshen, S., Hern, R. A., Gusterson, B. A., Taylor, C. R., Imam, S. A.; Anticancer Res. 2003 Jan 18.
See more >>
LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.
Liu, D., Baltayan, A., Naritoku, W. Y., Barr, N. J., Young, L. L., Chaiwun, B., Tsao-Wei, D. D., Groshen, S. L., Taylor, C. R., Torloni, H., Neville, A. M., Cote, R. J...; Anticancer Res. 2000 Aug 06.
See more >>
Reduction of BRCA1 expression in sporadic ovarian cancer.
Zheng, W., Luo, F., Lu, J. J., Baltayan, A., Press, M. F., Zhang, Z. F., Pike, M. C.; Gynecol Oncol. 2000 Mar.
See more >>